Literature DB >> 6811682

Distribution of high density lipoprotein particles with different apoprotein composition: particles with A-I and A-II and particles with A-I but no A-II.

M C Cheung, J J Albers.   

Abstract

High density lipoproteins (HDL) were subfractionated by equilibrium CsCl gradient centrifugation of the d 1.063-1.21 g/ml HDL fraction isolated from two men and two women. The various HDL subfractions were analyzed for their apoproteins (apo) A-I, A-II, B, D, and E and the major lipid contents. ApoA-I and A-II were found throughout the density gradient with the maximum concentration between the d 1.105 and 1.120 g/ml fractions. ApoE was found in all HDL fractions with the higher concentration in the lower density fractions. Conversely, the concentration of apoD increased as the density of the HDL fraction increased. Each density subfraction underwent quantitative precipitation with anti-A-I and anti-A-II immunoglobulin. Essentially all A-II in all density subfractions was precipitated with either immunoglobulin. Particles from each density subfraction precipitated with anti-A-II immunoglobulin had an A-I/A-II molar ratio of approximately 2.0 (range 1.9-2.3). However, particles precipitated with anti-A-I immunoglobulin had A-I/A-II molar ratios identical to the A-I/A-II ratio of the subfraction (range 2.1-7.1). The subfractions (d 1.105-1.149 g/ml fractions) with A-I/A-II molar ratios of about 2 had the least proportion of A-I in particles containing A-I but not A-II. Conversely, the subfractions (d 1.063-1.075 g/ml fractions) with the highest A-I/A-II molar ratio had the greatest proportion of apoA-I in particles containing A-I but not A-II. These data indicate that HDL contains at least two types of particles: particles with both A-I and A-II in a 2:1 molar ratio, and particles containing A-I but no A-II. The variation in A-I/A-II ratio observed in different HDL density subfractions was due to the different proportions of these two types of particles.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6811682

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  25 in total

1.  The isolation and characterization of high-density-lipoprotein subfractions containing apolipoprotein E from human plasma.

Authors:  H M Wilson; B A Griffin; C Watt; E R Skinner
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

2.  A comparison of the mouse and human lipoproteome: suitability of the mouse model for studies of human lipoproteins.

Authors:  Scott M Gordon; Hailong Li; Xiaoting Zhu; Amy S Shah; L Jason Lu; W Sean Davidson
Journal:  J Proteome Res       Date:  2015-04-27       Impact factor: 4.466

3.  Heterogeneity of high-density lipoprotein particles and insulin output during oral glucose tolerance test in men with coronary artery disease.

Authors:  J Iwanejko; M Kwaśniak; I Wybrańska; J Hartwich; I Guevara; A Zdzienicka; O Kruszelnicka-Kwiatkowska; W Piwowarska; B Miszczuk-Jamska; A Dembińska-Kieć
Journal:  Acta Diabetol       Date:  1996-03       Impact factor: 4.280

Review 4.  Synthetic high-density lipoprotein-like nanoparticles as cancer therapy.

Authors:  Kaylin M McMahon; Linda Foit; Nicholas L Angeloni; Francis J Giles; Leo I Gordon; C Shad Thaxton
Journal:  Cancer Treat Res       Date:  2015

5.  Characteristics of human lipoproteins isolated by selected-affinity immunosorption of apolipoprotein A-I.

Authors:  J P McVicar; S T Kunitake; R L Hamilton; J P Kane
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

6.  Postprandial lipemia. A key for the conversion of high density lipoprotein2 into high density lipoprotein3 by hepatic lipase.

Authors:  J R Patsch; S Prasad; A M Gotto; G Bengtsson-Olivecrona
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

7.  Limited discriminant value of lipoprotein AI, lipoprotein Lp(a) and other lipoprotein particles in patients with and without early onset ischaemic heart disease.

Authors:  D T Vallance; H A Staunton; A F Winder
Journal:  J Clin Pathol       Date:  1995-01       Impact factor: 3.411

8.  High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase.

Authors:  J R Patsch; S Prasad; A M Gotto; W Patsch
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

9.  Divergent mechanisms of interaction of Helicobacter pylori and Campylobacter jejuni with mucus and mucins.

Authors:  Julie Ann Naughton; Karina Mariño; Brendan Dolan; Colm Reid; Ronan Gough; Mary E Gallagher; Michelle Kilcoyne; Jared Q Gerlach; Lokesh Joshi; Pauline Rudd; Stephen Carrington; Billy Bourke; Marguerite Clyne
Journal:  Infect Immun       Date:  2013-05-28       Impact factor: 3.441

Review 10.  From High-Density Lipoprotein Cholesterol to Measurements of Function: Prospects for the Development of Tests for High-Density Lipoprotein Functionality in Cardiovascular Disease.

Authors:  Frank M Sacks; Majken K Jensen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-01-25       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.